AstraZeneca Aktie
122,70
EUR
-1,15
EUR
-0,93
%
101,34
GBP
-1,10
GBP
-1,07
%
AstraZeneca Aktie Analyse
| 29.03.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.03.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.03.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 05.03.19 | AstraZeneca buy | Deutsche Bank AG | |
| 28.02.19 | AstraZeneca Reduce | HSBC | |
| 26.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.02.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.02.19 | AstraZeneca overweight | Barclays Capital | |
|
Werbung
|
|||
| 25.02.19 | AstraZeneca overweight | Barclays Capital | |
| 18.02.19 | AstraZeneca buy | Deutsche Bank AG | |
| 15.02.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 14.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.02.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 14.02.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.01.19 | AstraZeneca buy | Deutsche Bank AG | |
| 02.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.12.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.12.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.12.18 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 14.12.18 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 11.12.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.12.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.11.18 | AstraZeneca Reduce | HSBC | |
| 19.11.18 | AstraZeneca Neutral | UBS AG | |
| 19.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 16.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 12.11.18 | AstraZeneca Reduce | HSBC | |
| 12.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 09.11.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 09.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.11.18 | AstraZeneca Hold | CFRA | |
| 09.11.18 | AstraZeneca overweight | Barclays Capital | |
| 08.11.18 | AstraZeneca Neutral | UBS AG | |
| 08.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.10.18 | AstraZeneca buy | Deutsche Bank AG | |
| 19.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 12.10.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 10.10.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 08.10.18 | AstraZeneca buy | Deutsche Bank AG | |
| 26.09.18 | AstraZeneca buy | Deutsche Bank AG | |
| 25.09.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 25.09.18 | AstraZeneca Neutral | UBS AG | |
| 24.09.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.09.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.09.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |